The purpose of this study was to evaluate the Wnt-signaling-mediated role of Dkk-3 and claudin-5 in in vitro studies on GBM cell lines, in in vivo study on TLR-4 KO mice and in a clinical study on 30 WHO grade IV GBM patients. Here, CLDN5 is linked to glioblastoma.